andecaliximab (GS-5745) / Gilead  >>  Phase 1
Welcome,         Profile    Billing    Logout  

6 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
andecaliximab (GS-5745) / Gilead
NCT02176876: Safety, Tolerability, and Pharmacokinetics of GS-5745 in Subjects With Rheumatoid Arthritis

Completed
1b
18
Europe
GS-5745, Placebo to match GS-5745
Gilead Sciences
Rheumatoid Arthritis
04/15
06/15
NCT02862535: Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Anti-Cancer Agents in Japanese Participants With Gastric or Gastroesophageal Junction Adenocarcinoma

Terminated
1b
36
Japan
Andecaliximab, GS-5745, S-1, Cisplatin, Oxaliplatin, Nivolumab
Gilead Sciences
Gastric Adenocarcinoma
10/19
10/19
NCT02209987: Absolute Bioavailability, Safety, and Tolerability of Subcutaneous GS-5745 in Healthy Adults

Completed
1
28
RoW
GS-5745 SC, GS-5745 IV
Gilead Sciences
Ulcerative Colitis
10/14
10/14
NCT02077465: Safety, Tolerability, and Pharmacokinetics of Andecaliximab in Adults With Chronic Obstructive Pulmonary Disease (COPD)

Completed
1
11
US
Andecaliximab, GS-5745, Placebo to match Andecaliximab
Gilead Sciences
Chronic Obstructive Pulmonary Disease
10/14
10/14
NCT01831427: Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of GS-5745 (Andecaliximab) in Adults With Moderate to Severe Active Ulcerative Colitis

Completed
1
74
Europe, Canada, US, RoW
Andecaliximab, GS-5745, Placebo to match Andecaliximab
Gilead Sciences
Ulcerative Colitis
01/15
02/15
NCT01803282: Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors

Checkmark From trial in combination with mFOLFOX in advanced unresectable gastric / GE junction tumors
Jan 2017 - Jan 2017: From trial in combination with mFOLFOX in advanced unresectable gastric / GE junction tumors
Completed
1
236
US
Andecaliximab, GS-5745, Gemcitabine, Nab-paclitaxel, Carboplatin, Pemetrexed, Leucovorin, Oxaliplatin, 5-FU, Bevacizumab, Irinotecan, Paclitaxel
Gilead Sciences
Pancreatic Cancer, Non-small Cell Lung Cancer, Esophagogastric Cancer, Colorectal Cancer, Breast Cancer
04/19
04/19

Download Options